Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Ligand sells cancer line to Eisai for $205mm

Executive Summary

Ligand Pharmaceuticals will sell its oncology product line and all associated assets to Eisai for $205mm in cash. Certain Ligand personnel will also be offered employment by Eisai.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Partial Acquisition
    • Includes Contract

Related Companies

UsernamePublicRestriction

Register